Iovance Biotherapeutics, Inc. (IOVA) vs MiniMed Group, Inc. Common Stock (MMED)
A side-by-side comparison of Iovance Biotherapeutics, Inc. and MiniMed Group, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IOVA
Iovance Biotherapeutics, Inc.
$13.33HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
MMED
MiniMed Group, Inc. Common Stock
$19.71HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — IOVA vs MMED
growth of $100 · dividends reinvested · last 1yIOVA +273.4% (+273.4%/yr)MMED +9.0% (+9.0%/yr)IOVA compounded faster over this window
IOVA MMED
IOVA vs MMED: by the numbers
- •IOVA is the larger company ($5.95B vs $5.54B market cap).
- •Both run net losses; MMED's is the smaller (-10.21% vs -89.09% net margin).
Metrics side by side
Valuation
| Metric | IOVA | MMED |
|---|---|---|
| Forward P/E | N/A | 29.27 |
| P/S ratio | 18.31 | 1.72 |
| P/B ratio | 8.08 | 1.53 |
| EV / EBITDA | N/A | 30.79 |
Profitability
| Metric | IOVA | MMED |
|---|---|---|
| Gross margin | 97.23% | 53.85% |
| Operating margin | -153.08% | 0.53% |
| Net margin | -89.09% | -10.21% |
| ROE | -39.33% | -9.09% |
| ROIC | -37.26% | 0.43% |
Growth (annualized)
| Metric | IOVA | MMED |
|---|---|---|
| Total return CAGR (5Y) | -11.55% | N/A |
Go deeper
Dig into the metrics
Iovance Biotherapeutics ROEMiniMed Group, Inc. Common Stock ROEIovance Biotherapeutics operating marginMiniMed Group, Inc. Common Stock operating marginIovance Biotherapeutics revenue growthMiniMed Group, Inc. Common Stock revenue growthIovance Biotherapeutics free cash flowMiniMed Group, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.